MBIO
Price:
$0.281
Market Cap:
$10.22M
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-107 and MB-207, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-102 CAR T therapi...[Read more]
Industry
Biotechnology
IPO Date
2017-08-22
Stock Exchange
NASDAQ
Ticker
MBIO
According to Mustang Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -76.36% compared to the average of -0.42 of the last 4 quarters.
The mean historical PE Ratio of Mustang Bio, Inc. over the last ten years is -7.09. The current -0.10 PE Ratio has changed 41.10% with respect to the historical average. Over the past ten years (40 quarters), MBIO's PE Ratio was at its highest in in the June 2024 quarter at -0.34. The PE Ratio was at its lowest in in the December 2015 quarter at -1058.21.
Average
-7.09
Median
-3.06
Minimum
-21.93
Maximum
-0.23
Discovering the peaks and valleys of Mustang Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.24%
Maximum Annual PE Ratio = -0.23
Minimum Annual Increase = -77.23%
Minimum Annual PE Ratio = -21.93
Year | PE Ratio | Change |
---|---|---|
2023 | -0.23 | -56.57% |
2022 | -0.52 | -77.23% |
2021 | -2.28 | -28.92% |
2020 | -3.20 | 4.84% |
2019 | -3.06 | 18.24% |
2018 | -2.58 | -73.30% |
2017 | -9.68 | -52.37% |
2016 | -20.32 | -7.36% |
The current PE Ratio of Mustang Bio, Inc. (MBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.01
5-year avg
-1.86
10-year avg
-7.09
Mustang Bio, Inc.’s PE Ratio is greater than Checkpoint Therapeutics, Inc. (-1.81), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.10), greater than Fortress Biotech, Inc. (-0.71), greater than Kodiak Sciences Inc. (-0.61), greater than Fortress Biotech, Inc. (-0.71), greater than Achilles Therapeutics plc (-0.45), greater than Aptose Biosciences Inc. (-0.15), less than Aditxt, Inc. (-0.02), greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Dermata Therapeutics, Inc. (-0.11), greater than Unicycive Therapeutics, Inc. (-0.46), less than Revelation Biosciences, Inc. (-0.09), greater than Affimed N.V. (-0.66), greater than Leap Therapeutics, Inc. (-1.83), greater than Adaptimmune Therapeutics plc (-3.82), greater than Corvus Pharmaceuticals, Inc. (-10.64), greater than Akari Therapeutics, Plc (-1.55), greater than Salarius Pharmaceuticals, Inc. (-0.14), greater than Axcella Health Inc. (-10.73), less than Magenta Therapeutics, Inc. (-0.04), less than Histogen Inc. (-0.10),
Company | PE Ratio | Market cap |
---|---|---|
-1.81 | $93.07M | |
-1.10 | $44.68M | |
-0.71 | $44.00M | |
-0.61 | $121.54M | |
-0.71 | $40.38M | |
-0.45 | $29.58M | |
-0.15 | $6.57M | |
-0.02 | $1.68M | |
-0.73 | $29.70M | |
-0.11 | $2.08M | |
-0.46 | $33.41M | |
-0.09 | $1.43M | |
-0.66 | $57.26M | |
-1.83 | $107.52M | |
-3.82 | $278.72M | |
-10.64 | $252.08M | |
-1.55 | $35.02M | |
-0.14 | $2.15M | |
-10.73 | $0 | |
-0.04 | $42.44M | |
-0.10 | $939.79K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mustang Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mustang Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mustang Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Mustang Bio, Inc. (MBIO)?
What is the highest PE Ratio for Mustang Bio, Inc. (MBIO)?
What is the 3-year average PE Ratio for Mustang Bio, Inc. (MBIO)?
What is the 5-year average PE Ratio for Mustang Bio, Inc. (MBIO)?
How does the current PE Ratio for Mustang Bio, Inc. (MBIO) compare to its historical average?